ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial
ChemoID指导的治疗可提高复发性铂耐药卵巢癌的客观缓解率:随机临床试验
期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-00874-0
Herzog, Thomas J; Krivak, Thomas C; Bush, Stephen 2nd; Diaz, John P; Lentz, Scott; Nair, Navya; Zgheib, Nadim Bou; Gunderson-Jackson, Camille; Barve, Abhijit; Denning, Krista L; Lirette, Seth T; Howard, Candace M; Valluri, Jagan; Claudio, Pier Paolo